SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
SGTX
Delisted
SGTX was delisted on the 10th of August, 2023.
32 hedge funds and large institutions have $16.5M invested in Sigilon Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 5 closing their positions.
Holders
32
Holders Change
–
Holders Change %
0%
% of All Funds
0.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
7
Reduced
6
Closed
5
Calls
$27K
Puts
$1K
Net Calls
+$26K
Net Calls Change
+$17K
Top Buyers
Top Sellers
1 |
1
Renaissance Technologies
New York
|
$90K |
2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$89.8K |
3 |
E
3
Ergoteles
New York
|
$0 |
4 |
4
BlackRock
New York
|
$976K |
5 |
5
Citadel Advisors
Miami,
Florida
|
$0 |